Otonomy to Participate in the H.C. Wainwright BioConnect Conference

Back to Jobs

SAN DIEGO , Jan. 03, 2022 (GLOBE NEWSWIRE) — Otonomy , Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced its participation in the H.C. Wainwright BioConnect Virtual Conference.

Apply Now